• Explore /
  • Poster
  • / Aggressive end-of-life (EOL) chemotherapy (CT) use in metastatic non-small cell lung cancer (mNSCLC): A National Comprehensive Cancer Network (NCCN) outcomes database analysis.

Aggressive end-of-life (EOL) chemotherapy (CT) use in metastatic non-small cell lung cancer (mNSCLC): A National Comprehensive Cancer Network (NCCN) outcomes database analysis.

Abstract Poster

Authors

null

K. E. Bickel

University of Michigan Comprehensive Cancer Center, Ann Arbor, MI

K. E. Bickel , J. C. Niland , R. Mamet , C. C. Zornosa , D. S. Ettinger , K. Pisters , G. A. Otterson , M. Koczywas , M. E. Reid , M. S. Rabin , T. A. D'Amico , C. Earle , T. M. Pini , G. P. Kalemkerian

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2011 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Lung Cancer - Metastatic/Non-small Cell

Track

Lung Cancer

Sub Track

Metastatic

Citation

J Clin Oncol 29: 2011 (suppl; abstr 7537)

Abstract #

7537

Poster Bd #

32A

Abstract Disclosures

Similar Posters

First Author: Li Zhang

Poster

2016 Palliative and Supportive Care in Oncology Symposium

Using cancer registry records linked with health insurance records to measure costs and services at end-of-life.

Using cancer registry records linked with health insurance records to measure costs and services at end-of-life.

First Author: Karma L. Kreizenbeck

Poster

2014 Palliative and Supportive Care in Oncology Symposium

Processes of discontinuing chemotherapy for metastatic non-small cell lung cancer at the end of life.

Processes of discontinuing chemotherapy for metastatic non-small cell lung cancer at the end of life.

First Author: William F. Pirl

First Author: Martin H. Schuler